• 0.4% Trypan Blue Solution: Practical Cell Counting

  2026-08-26

  0.4% Trypan Blue Solution provides a direct membrane-integrity readout for cell viability measurement, routine cell counting, and cytotoxicity assay workflows. It is intended for scientific research only and should not be used for diagnostic, clinical, or medical decisions.

• GSK621: AMPK Agonist Workflows for AML and Immunometabolism

  2026-08-26

  GSK621 is a practical AMPK agonist for connecting energy sensing with AML viability, autophagy, lipid metabolism, and macrophage-state assays. This guide translates the 2024 Immunity discovery on lysosomal 25-hydroxycholesterol into controlled experiments that distinguish AMPK sufficiency from upstream lipid-signaling effects.

• Diethylmaleate for Redox and GST Research

  2026-08-25

  Diethylmaleate is a small-molecule GSH-depletion tool for oxidative stress, redox regulation, and toxicology research. In a 2024 insect study, diethyl maleate inhibited GST activity by 64.05% and increased lambda-cyhalothrin sensitivity 7.91-fold under the reported experimental conditions.

• Pyridostigmine, α7 nAChR, and Placental Necroptosis

  2026-08-25

  The reference study identifies placental necroptosis as a modifiable component of preeclampsia-like pathology and shows that pyridostigmine improves ischemia-associated outcomes through α7 nicotinic acetylcholine receptor signaling. Pharmacological blockade with α-bungarotoxin and comparison with necrostatin-1 provide a useful framework for separating cholinergic receptor dependence from general necroptosis inhibition.

• GST-Driven Lambda-Cyhalothrin Resistance in M. usitatus

  2026-08-24

  Dong et al. show that MuGSTs1-mediated glutathione S-transferase activity helps Megalurothrips usitatus withstand lambda-cyhalothrin by reinforcing antioxidant defenses. Pharmacological GST inhibition with diethyl maleate reduced antioxidant capacity and sharply increased insecticide sensitivity, providing causal evidence that redox protection contributes to resistance.

• TaqI Restriction Endonuclease Protocol Guide

  2026-08-24

  TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the TCG A recognition site. This guide covers setup, gel-based QC, and troubleshooting while defining the limits of the available product evidence; the enzyme is for scientific research use only, not diagnostic or medical applications.

• Lipo3K Transfection Reagent: Assay Reliability

  2026-08-23

  This scenario-based guide explains how Lipo3K Transfection Reagent, SKU K2705, can reduce transfection-related variability in viability, proliferation, cytotoxicity, gene expression, and RNA interference workflows. It connects product-supported performance characteristics with practical controls, timing, compatibility decisions, and vendor-selection criteria.

• Artesunate B3662: Reliable Cytotoxicity Assays

  2026-08-22

  Learn how Artesunate (SKU B3662) can be integrated into better-controlled viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects solvent handling, dose design, ferroptosis-focused interpretation, and supplier selection with quantitative product data and the distinction between relative and fractional viability.

• Scalable EPSC-Derived MSC Extracellular Vesicles

  2026-08-22

  Gong and colleagues developed a bioreactor-based platform that generates induced mesenchymal stem cells from extended pluripotent stem cells and continuously harvests their extracellular vesicles. The resulting vesicles showed primary MSC-EV-like characteristics and reduced fibrosis-associated injury in a bleomycin mouse model, supporting a more standardized route toward therapeutic EV manufacturing.

• Polystyrene Microplastics and DDIT4-Mediated Nephrotoxicity

  2026-08-21

  The reference study uses human pluripotent stem cell-derived kidney organoids to show that 1 μm polystyrene microplastics impair nephron development through DDIT4-associated inhibition of mTOR signaling, autophagy, and apoptosis. Its combination of a developmentally relevant 3D model, transcriptomic analysis, and DDIT4 silencing provides a useful framework for mechanistic nephrotoxicity research.

• Methotrexate in Psoriasis Assay Design

  2026-08-20

  Methotrexate is a folate antagonist with distinct cytostatic, apoptotic, and anti-inflammatory effects. This guide translates psoriasis pathway findings into a practical assay-design framework for separating DHFR inhibition from immune signaling changes.

• Cytochalasin B: Actin Mechanism and Research Use

  2026-08-20

  Cytochalasin B, also called NSC 107658, is a cell-permeable actin-disrupting mycotoxin used as a cytoskeletal research tool. Its reversible barbed-end activity supports mechanistic studies of actin filament dynamics, cell motility, division, phagocytosis, and glucose transport, but its broad pharmacology limits clinical interpretation.

• EDI3 in HER2 Therapy–Resistant Breast Cancer

  2026-08-19

  Keller et al. identify the glycerophosphodiesterase EDI3/GPCPD1 as a metabolically linked vulnerability in estrogen receptor-positive, HER2-positive breast cancer, including models resistant to HER2-targeted treatment. Their combination of patient-tissue analysis, pathway perturbation, genetic silencing, pharmacological inhibition, and in vivo testing supports EDI3 as a candidate target, while also defining important limits for translation.

• Anlotinib Hydrochloride: Angiogenesis Workflows

  2026-08-19

  Anlotinib hydrochloride provides a practical way to connect VEGFR2, PDGFRβ, and FGFR1 blockade with endothelial migration, tube formation, and ERK pathway readouts. This guide translates the compound’s anti-angiogenic profile and a notable desmoplastic small round cell tumor case report into reproducible cancer research workflows and troubleshooting decisions.

• CARMIL Membrane-Binding Domain and Actin Assembly

  2026-08-18

  Mooren and colleagues show that the CARMIL membrane-binding domain is an active regulator rather than a passive membrane tether: it recruits capping protein (CP) to lipid surfaces, then can dissociate after CP binding. The findings provide a biochemical explanation for how CARMIL may coordinate membrane localization, barbed-end uncapping, and Arp2/3-dependent actin assembly.

8560 records 1/571 page Next 12345 下5页 Last page